Prime Time for G-Protein-Coupled Receptor Heteromers as Therapeutic Targets for CNS disorders: The Dopamine D1-D3 Receptor Heteromer

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|9|5|596-600

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.9, Iss.5, 2010-11, pp. : 596-600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 1, 2006-02 ,pp. : 25-43

Bentham Science Publishers

Access to resources Recommend Favorite

Novel G-protein-coupled receptor genes expressed in the brain: continued discovery of important therapeutic targets

By O’Dowd Brian F   Lee Dennis K   George Susan R  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 2, 2002-04 ,pp. : 185-202

Informa Healthcare

Access to resources Recommend Favorite

D2 Receptor Partial Agonists: Treatment of CNS Disorders of Dopamine Function

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-08 ,pp. : 1068-1088

Bentham Science Publishers

Access to resources Recommend Favorite

G-protein-coupled receptor websites

By Rana B.K.   Insel P.A.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 11, 2002-11 ,pp. : 535-536

Elsevier

Access to resources Recommend Favorite

Elimination of palmitoylation sites in the human dopamine D 1 receptor does not affect receptor-G protein interaction

By Jin H.   Zastawny R.   George S.R.   O'Dowd B.F.  

European Journal of Pharmacology, Vol. 324, Iss. 1, 1997-04 ,pp. : 109-116

Elsevier

Access to resources Recommend Favorite